Lebrun-Frenay C - Search Results

1

Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review.

Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Levraut M, et al. Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4):e568. doi: 10.1212/NXI.0000000000000568. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355304 Free PMC article. Review.

2

EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.

Burel-Vandenbos F, Benchetrit M, Miquel C, Fontaine D, Auvergne R, Lebrun-Frenay C, Cardot-Leccia N, Michiels JF, Paquis-Flucklinger V, Virolle T. Burel-Vandenbos F, et al. J Neurooncol. 2011 Apr;102(2):171-8. doi: 10.1007/s11060-010-0308-4. Epub 2010 Jul 24. J Neurooncol. 2011. PMID: 20652725

3

[TNF inhibitors and myelitis: think about it, even lately].

Stève-Dumont M, Cohen M, Lebrun-Frenay C, Rocher F. Stève-Dumont M, et al. Therapie. 2014 Sep-Oct;69(5):473-7. doi: 10.2515/therapie/2014031. Epub 2014 Oct 1. Therapie. 2014. PMID: 25269140 French.

4

[Gliomas and BRCA genes mutations: fortuitous association or imputability?].

Girardstein-Boccara L, Mari V, Met-Domestici M, Burel-Vandenbos F, Berthet P, Paquis P, Frenay MP, Lebrun-Frenay C. Girardstein-Boccara L, et al. Bull Cancer. 2014 Sep;101(9):795-802. doi: 10.1684/bdc.2014.1952. Bull Cancer. 2014. PMID: 25295380 French.

5

Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.

Romero G, Ticchioni M, Cohen M, Rosenthal-Allieri MA, Mondot L, Lebrun Frenay C. Romero G, et al. Rev Neurol (Paris). 2016 Mar;172(3):220-4. doi: 10.1016/j.neurol.2015.12.004. Epub 2016 Feb 23. Rev Neurol (Paris). 2016. PMID: 26915311 Review.

6

Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?

Van Obberghen EK, Cohen M, Rocher F, Lebrun-Frenay C. Van Obberghen EK, et al. Rev Neurol (Paris). 2017 Apr;173(4):222-224. doi: 10.1016/j.neurol.2017.03.008. Epub 2017 Mar 31. Rev Neurol (Paris). 2017. PMID: 28372806

7

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

Sirven-Villaros L, Bourg V, Suissa L, Mondot L, Almairac F, Fontaine D, Paquis P, Burel-VandenBos F, Frenay M, Thomas P, Lebrun-Frenay C. Sirven-Villaros L, et al. Bull Cancer. 2018 Dec;105(12):1135-1146. doi: 10.1016/j.bulcan.2018.07.010. Epub 2018 Oct 6. Bull Cancer. 2018. PMID: 30301554

8

Impact of executive dysfunction on naming ability in multiple sclerosis.

Joly H, Cohen M, Bresch S, Lebrun-Frenay C. Joly H, et al. Rev Neurol (Paris). 2019 Oct;175(9):552-559. doi: 10.1016/j.neurol.2019.02.008. Epub 2019 Jun 17. Rev Neurol (Paris). 2019. PMID: 31221416 No abstract available.

9

Complementary and alternative medicine use in glioma patients in France.

Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M. Le Rhun E, et al. J Neurooncol. 2019 Dec;145(3):487-499. doi: 10.1007/s11060-019-03315-8. Epub 2019 Oct 21. J Neurooncol. 2019. PMID: 31637628 Free article.

10

Video-oculography in multiple sclerosis: Links between oculomotor disorders and brain magnetic resonance imaging (MRI).

Polet K, Hesse S, Cohen M, Morisot A, Joly H, Kullmann B, Mondot L, Pesce A, Lebrun-Frenay C. Polet K, et al. Mult Scler Relat Disord. 2020 May;40:101969. doi: 10.1016/j.msard.2020.101969. Epub 2020 Jan 28. Mult Scler Relat Disord. 2020. PMID: 32028119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters